Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)	Solid Tumor, Adult	Active, not recruiting	Phase 1 / Phase 2	2026-08-19		NCT04725474

Clinical trials